Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 9/20 | 0.78 |
| ▸ | HTR2A | P28223 | 4/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.45 |
| ▸ | HTR2C | P28335 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4483830 | 0.91 | MCHR1 (0.79) | MCHR1HTR2ACHRM1KDM4EKMT2A | |
| SCHEMBL2322339 | 0.88 | MCHR1 (1.00) | MCHR1HTR2ACHRM1KDM4ECYP2D6 | |
| SCHEMBL4487952 | 0.87 | MCHR1 (0.59) | MCHR1HTR2ACHRM1CYP2D6 | |
| SCHEMBL4482386 | 0.83 | MCHR1 (0.54) | MCHR1HTR2ACHRM1KDM4EKMT2A | |
| SCHEMBL4482390 | 0.83 | MCHR1 (0.54) | MCHR1HTR2ACHRM1KDM4EKMT2A | |
| SCHEMBL4487720 | 0.83 | MCHR1 (0.80) | MCHR1HTR2ACHRM1KDM4ECYP2D6 | |
| SCHEMBL4478680 | 0.82 | MCHR1 (0.63) | MCHR1HTR2ACHRM1KDM4EALDH1A1 | |
| SCHEMBL4475717 | 0.82 | MCHR1 (0.63) | MCHR1HTR2ACHRM1KDM4EALDH1A1 | |
| SCHEMBL4492887 | 0.82 | MCHR1 (0.50) | MCHR1HTR2ACHRM1KDM4EKMT2A | |
| SCHEMBL4491986 | 0.82 | MCHR1 (0.53) | MCHR1HTR2ACHRM1KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592358-B2 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-09-22 | — | — | US | claimed |
| US-20050234101-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234101-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | MCHR1, GPR119, MCHR2 | MCHR1 1/4885HTR2A 161/4885CHRM1 125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.